首页> 外国专利> METHODS OF MODULATING ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY

METHODS OF MODULATING ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY

机译:调节依赖性细胞介导的细胞毒性的方法

摘要

The present disclosure provides a method of controlling the Antibody Dependent Cellular Cytotoxicity (ADCC) activity of a glycosylated and afucosylated IgG1 antibody composition. In exemplary embodiments, the method includes (1) determining the ADCC activity of a glycosylated and afucosylated IgG1 antibody composition; and (2) increasing or decreasing the ADCC activity of the IgG1 antibody composition by increasing or decreasing the amount of terminal β-galactose in the afucosylated glycan species at the consensus glycosylation site. Related methods of matching ADCC activity of a reference glycosylated and afucosylated IgG1 antibody composition and methods of engineering a specific target ADCC activity of a glycosylated and afucosylated IgG1 antibody composition are further provided herein.
机译:本公开提供了一种控制糖基化的抗体依赖性细胞细胞毒性(ADCC)活性的方法,其糖基化和逐渐抑制的IgG1抗体组合物。 在示例性实施方案中,该方法包括(1)确定糖基化的糖基化的糖基化的IgG1抗体组合物的ADCC活性; (2)通过增加或减少在共有糖基化位点在糖基化位点上增加或减少逐渐减少的末端β-半乳糖的末端β-半乳糖的量来增加或减少IgG1抗体组合物的ADCC活性。 本文还提供了匹配参考糖基化和逐渐消耗的IgG1抗体组合物的ADCC活性的相关方法及其工程方法的特定靶标ADCC活性的糖基化和逐渐溶解的IgG1抗体组合物。

著录项

  • 公开/公告号US2022033511A1

    专利类型

  • 公开/公告日2022-02-03

    原文格式PDF

  • 申请/专利权人 AMGEN INC.;

    申请/专利号US201917275140

  • 申请日2019-09-10

  • 分类号C07K16/28;C07K16/32;C07K16/24;

  • 国家 US

  • 入库时间 2022-08-24 23:36:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号